ArticleAmerican journal of obstetrics and gynecology2026
Translation of chronic pelvic pain experience into patient treatment preference profiles with Q-methodology.
Article in American journal of obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDespite many available treatments for female chronic pelvic pain, there is limited patient success, engagement, or compliance with therapy. No current methods allow providers to effectively collect and integrate patient perspectives into treatment choice for female chronic pelvic pain.
objectiveWe aimed to leverage former qualitative stakeholder input on female chronic pelvic pain treatment choice, patient advisory group input, and Q-methodology to translate patient viewpoints around female chronic pelvic pain treatment into measurable patient viewpoints to guide treatment choice. STUDY
designWe used Q-methodology to translate qualitative data formerly collected from stakeholders in female chronic pelvic pain treatment into measurable patient preference profiles. Patient advisory group members interpreted previously collected qualitative data from female chronic pelvic pain stakeholders, and their guidance formulated Q-set statements in English and Spanish. Patients with female chronic pelvic pain performed Q-sort of these statements. Patient advisory group input then guided interpretation of factor analyses of Q-sorts to form relevant patient preference profiles for female chronic pelvic pain and provided preliminary mapping to certain treatments that may resonate with patients aligned with each preference profile.
resultsWe engaged 11 patient advisory group members, and 47 patients completed Q-sort. The authors and the patient advisory group analyzed, interpreted, and described 5 factors (patient preference profiles) to measure female chronic pelvic pain treatment viewpoints. We titled these patient preference profiles as the "Self-empowered Realist," the "Fearless Escalator," the "Careful Scientist," the "Trusting Optimist," and "Eager to Move On," with each patient having a certain alignment with each of these viewpoints. These factors map to possible treatments that align with a patient's viewpoint as they align with one or more of these patient preference profiles. We described the perspectives associated with each patient preference profile to allow for future use of these profiles to inform instruments to measure patient preferences in female chronic pelvic pain treatment navigation.
conclusionWe translated patient perspectives on female chronic pelvic pain treatment into 5 measurable, nuanced patient preference profiles. We plan to use these patient preference profiles to guide treatment option counseling for female chronic pelvic pain in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.